Effect of a cancer vaccine prepared by fusions of hepatocarcinoma cells with dendritic cells

Abstract

AIM To prepare a cancer vaccine (H22-DC) expressing high levels of costimulatory molecules based on fusions of hepatocarcinoma cells (H 22 ) with dendritic cells (DC) of mice and to analyze the biological characteristics and induction of specific CTL activity of H22-DC.METHODS DCs were isolated from murine spleen by metrizamide density gradient centrifugation, purified based on its characteristics of semi-adhesion to culture plates and FcR -, and were cultured in the medium containing GM-CSF and IL-4. A large number of DC were harvested. DCs were then fused with H22 cells by PEG and the fusion cells were marked with CD11c MicroBeads. The H 22 -DC was sorted with Mimi MACS sorter. The techniques of cell culture, immunocytochemistry and light microscopy were also used to test the characteristics of growth and morphology of H 22 -DC in vitro. As the immunogen, H 22 -DC was inoculated subcutaneously into the right armpit of BALB/C mice, and their tumorigenicity in vivo was observed. MTT was used to test the CTL activity of murine spleen in vitro.RESULTS DC cells isolated and generated were CD11c+ cells with irregular shape, and highly expressed CD80, CD86 and CD54 molecules. H 22 cells were CD11c-cells with spherical shape and bigger volume, and did not express CD80, CD86 and CD54 molecules. H22-DC was CD11c+ cells with bigger volume, being spherical, flat or irregular in shape, and highly expressed CD80, CD86 and CD54 molecules, too. H 22 -DC was able to divide and proliferate in vitro, but its activity of proliferation was significantly decreased as compared with H22 cells and its growth curve was flatter than H 22 cells. After subcutaneous inoculation over 60 days, H 22 -DC showed no tumorigenecity in mice, which was significantly different from control groups (P<0.01). The spleen CTL activity against H 22 cells in mice implanted with fresh H 22 -DC was significantly higher than control groups (P<0.01).CONCLUSION H 22 -DC could significantly stimulate the specific CTL activity of murine spleen, which suggests that the fusion cells have already obtained the function of antigen presenting of parental DC and could present H 22 specific antigen which has not been identified yet, and H22-DC could induce antitumor immune response; although simply mixed H 22 cells with DC could stimulate the specific CTL activity which could inhibit the growth of tumor in some degree, it could not prevent the generation of tumor. It shows that the DC vaccine is likely to become a helpful approach in immunotherapy of hepatocarcinoma.Subject headings cancer vaccine; dendritic cells; hepatocarcinoma cells; cell fusion; spleen; mouse Zhang J, Zhang JK, Zhuo SH, Chen HB. Effect of a cancer vaccine prepared by fusions of hepatocarcinoma cells with dendritic cells.

Efficient Activation of Autologous Tumor-specific T Cells: A Simple Coculture Technique of Autologous Dendritic Cells Compared to Established Cell Fusion Strategies in Primary Human Colorectal Carcinoma

“…15,19 But, especially for human primary solid tumors there are few reports comparing both strategies systematically. After comparative studies of DC/tumor cell fusion and coculture techniques in murine models 31,41,47,48 and human cell lines, 44 it has been done in human melanoma, 12 ovarian and breast carcinoma. 10,11 So far, there were no publications investigating both 49 investigating both a murine melanoma and a lung tumor model were the first who reported about similar efficacies in tumor cell uptake after cell fusion respectively simple coculture without any cell manipulation.…”

Induction of cytotoxic T-lymphocyte responses using dendritic cells transfected with hepatocellular carcinoma mRNA

“…[32][33][34] Tumour cells themselves could be used as immunogens, as they are thought to be able to express a set of tumour-specific peptide-MHC complexes recognised by CTLs. Although many reports have described the establishment and characterisation of tumour-specific CTLs and their possible therapeutic effects, the induction of human CTLs against HCC has not been easy.…”

Immunologic Function of Dendritic Cells in Esophageal Cancer

“…The majority of experimental systems clearly demonstrate that tumor cells are largely defended by CD4 + , CD8 + T lymphocytes, or NK cells [8][9][10]. Lymphocyte T and possibly NK cells require activation by APCs.…”